162 related articles for article (PubMed ID: 30118322)
1. Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension.
Wang Y; Wang E; Zhang Y; Madamsetty VS; Ji B; Radisky DC; Grande JP; Misra S; Mukhopadhyay D
FASEB J; 2019 Jan; 33(1):494-500. PubMed ID: 30118322
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.
Hu X; Xu X; Zhu G; Atzler D; Kimoto M; Chen J; Schwedhelm E; Lüneburg N; Böger RH; Zhang P; Chen Y
Circulation; 2009 Dec; 120(22):2222-9. PubMed ID: 19917889
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
[TBL] [Abstract][Full Text] [Related]
4. Vascular peroxidase 1 up regulation by angiotensin II attenuates nitric oxide production through increasing asymmetrical dimethylarginine in HUVECs.
Peng H; Chen L; Huang X; Yang T; Yu Z; Cheng G; Zhang G; Shi R
J Am Soc Hypertens; 2016 Sep; 10(9):741-751.e3. PubMed ID: 27475679
[TBL] [Abstract][Full Text] [Related]
5. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
7. miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia.
Iannone L; Zhao L; Dubois O; Duluc L; Rhodes CJ; Wharton J; Wilkins MR; Leiper J; Wojciak-Stothard B
Biochem J; 2014 Aug; 462(1):103-12. PubMed ID: 24895913
[TBL] [Abstract][Full Text] [Related]
8. Basal release of nitric oxide in the mesenteric artery in portal hypertension and cirrhosis: role of dimethylarginine dimethylaminohydrolase.
Serna E; Mauricio MD; Lluch P; Segarra G; Cortina B; Lluch S; Medina P
J Gastroenterol Hepatol; 2013 May; 28(5):880-6. PubMed ID: 23302093
[TBL] [Abstract][Full Text] [Related]
9. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
[TBL] [Abstract][Full Text] [Related]
10. A role for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) in mammalian development.
Breckenridge RA; Kelly P; Nandi M; Vallance PJ; Ohun TJ; Leiper J
Int J Dev Biol; 2010; 54(1):215-20. PubMed ID: 19757398
[TBL] [Abstract][Full Text] [Related]
11. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
Zhang P; Hu X; Xu X; Chen Y; Bache RJ
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
Dowsett L; Piper S; Slaviero A; Dufton N; Wang Z; Boruc O; Delahaye M; Colman L; Kalk E; Tomlinson J; Birdsey G; Randi AM; Leiper J
Circulation; 2015 Jun; 131(25):2217-25. PubMed ID: 25910799
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
14. Dimethylarginine dimethylaminohydrolase-1 contributes to exercise-induced cardiac angiogenesis in mice.
Shi X; Luo X; Xu X
Biosci Trends; 2020 May; 14(2):115-122. PubMed ID: 32238672
[TBL] [Abstract][Full Text] [Related]
15. Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice.
Jacobi J; Maas R; Cordasic N; Koch K; Schmieder RE; Böger RH; Hilgers KF
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H1058-66. PubMed ID: 18156199
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
[TBL] [Abstract][Full Text] [Related]
17. Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity.
Sun T; Zhou JP; Kuang DB; Li MP; Xiong Y; Tang J; Xia J; Bai YP; Yang GP; Li YJ; Chen XP
Am J Hypertens; 2013 Dec; 26(12):1437-44. PubMed ID: 23864585
[TBL] [Abstract][Full Text] [Related]
18. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
19. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
[TBL] [Abstract][Full Text] [Related]
20. The asymmetric dimethylarginine-mediated inhibition of nitric oxide in the rostral ventrolateral medulla contributes to regulation of blood pressure in hypertensive rats.
Tan X; Li JK; Sun JC; Jiao PL; Wang YK; Wu ZT; Liu B; Wang WZ
Nitric Oxide; 2017 Jul; 67():58-67. PubMed ID: 28392446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
